Zevra therapeutics to participate at upcoming investor conferences

Celebration, fla., feb. 28, 2024 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra or the company), a rare disease therapeutics company, today announced that neil f. mcfarlane, president and chief executive officer of zevra, will present at upcoming investor conferences in march 2024. additionally, management will be available for one-on-one meetings with registered attendees at each of the conferences.
ZVRA Ratings Summary
ZVRA Quant Ranking